Rachel M. Frankeny

Rachel M. Frankeny

Counsel, Mergers and Acquisitions
Rachel M. Frankeny concentrates her practice in the areas of mergers and acquisitions, strategic investments, and general corporate and securities matters.

Bio

Ms. Frankeny represents companies, private equity funds and high-net-worth individuals in a variety of public and private transactions, including negotiated and contested public acquisitions, spin-offs, internal reorganizations, majority and minority investments, and joint ventures across a broad range of industries, including media, health care, technology, real estate and energy. She also advises clients on a range of corporate governance and related matters.

Her significant representations include, among others:

  • Gannett Co., Inc. in its:
    • $1.4 billion acquisition by New Media Investment Group Inc.;
    • receipt of an unsolicited proposal from MNG Enterprises, Inc. and subsequent successful proxy contest against MNG;
    • $280 million acquisition of Journal Media Group, Inc.;
    • $130 million acquisition of WordStream, Inc.; and
    • proposed but terminated unsolicited acquisition of tronc, Inc. (formerly Tribune Publishing);
  • Hawaiian Electric Industries, Inc. in its proposed but terminated $4.3 billion acquisition by NextEra Energy, Inc. and spin-off of American Savings Bank, F.S.B.;
  • Alexander & Baldwin, Inc. in its:
    • $235 million acquisition of Grace Pacific Corporation, a privately held general contracting company; and
    • conversion to a real estate investment trust;
  • an investor in the $5 billion (enterprise value) acquisition of a U.S.-based, NYSE-listed utility company;
  • Davidson Kempner Capital Management LP, a global institutional investment management firm, in its acquisition of Devonshire Operating Partnership, LP, a privately held real estate investment trust;
  • Medical Professional Mutual Insurance Company, a Coverys company, in its acquisition of Preferred Professional Insurance Company;
  • The AES Corporation in its $244 million sale of a 15% stake in AES US Investments, Inc. to La Caisse de dépôt et placement du Québec (CDPQ), in connection with which CDPQ also acquired an 18% stake in IPALCO Enterprises, Inc. from The AES Corporation for $349 million; and
  • Valeant Pharmaceuticals International, Inc. in its $414 million acquisition of the outstanding common stock of Obagi Medical Products, Inc.

Credentials

Education

  • J.D., Harvard Law School, 2012
  • B.A., Baylor University, 2009

Admissions

  • Texas
  • District of Columbia

Rachel M. Frankeny